CSPC Innovation Pharmaceutical's latest marketcap:
As of 06/18/2025, CSPC Innovation Pharmaceutical's market capitalization has reached $10.85 B. According to our data, CSPC Innovation Pharmaceutical is the 1783th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 10.85 B |
| Revenue (ttm) | 268.28 M |
| Net Income (ttm) | -7,266,104.11 |
| Shares Out | 1.39 B |
| EPS (ttm) | -0.01 |
| Forward PE | 106.94 |
| Ex-Dividend Date | 05/29/2025 |
| Earnings Date | 08/15/2025 |
CSPC Innovation Pharmaceutical's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | ¥10.85 B | 121.62% | 1783 |
| 12/31/2024 | ¥37.03 B | -13.63% | 2963 |
| 12/29/2023 | ¥42.87 B | 338.97% | 2469 |
| 12/30/2022 | ¥9.77 B | 16.61% | 6680 |
| 12/31/2021 | ¥8.38 B | 6.58% | 7918 |
| 12/31/2020 | ¥7.86 B | 10.06% | 7151 |
| 12/31/2019 | ¥7.14 B | 6743 |
Company Profile
About CSPC Innovation Pharmaceutical Co., Ltd.
CSPC Innovation Pharmaceutical Co., Ltd. is a leading biopharmaceutical company specializing in the research, development, production, and sales of:
- Biopharmaceuticals
- Active Pharmaceutical Ingredients (APIs)
- Functional foods
Key Offerings
The company provides a diverse range of products, including:
Functional Raw Ingredients:- Caffeine
- Acarbose
- Anhydrous glucose
- Theophylline
- Aminophylline
- Dihydroxyphylline
- Theobromine
- Pentoxifylline
- Doxofylline
- Raw enzymes
- Guoweikang Vitamin C tablets
- Guoweikang B vitamin lozenges
Company Background
Founded in 2006 and headquartered in Shijiazhuang, China, CSPC Innovation Pharmaceutical Co., Ltd. operates as a subsidiary of CSPC NBP Pharmaceutical Co., Ltd. The company serves both domestic and international markets.
Frequently Asked Questions
-
What is CSPC Innovation Pharmaceutical's (SHE-300765) current market cap?As of 06/18/2025, CSPC Innovation Pharmaceutical (including the parent company, if applicable) has an estimated market capitalization of $10.85 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CSPC Innovation Pharmaceutical (SHE-300765) rank globally by market cap?CSPC Innovation Pharmaceutical global market capitalization ranking is approximately 1783 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.